89 related articles for article (PubMed ID: 18836117)
1. Review: erythropoiesis-stimulating agents increase mortality and venous thromboembolism in cancer-associated anaemia.
Thomé S
Evid Based Med; 2008 Oct; 13(5):149. PubMed ID: 18836117
[No Abstract] [Full Text] [Related]
2. Review: erythropoiesis-stimulating agents increase mortality and venous thromboembolism in cancer-associated anemia.
Thomé S
ACP J Club; 2008 Aug; 149(2):8. PubMed ID: 18710181
[No Abstract] [Full Text] [Related]
3. VTE and mortality associated with erythropoiesis-stimulating agents in cancer-associated anemia.
Dronca RS; Steensma DP
Nat Clin Pract Oncol; 2008 Sep; 5(9):504-5. PubMed ID: 18648351
[TBL] [Abstract][Full Text] [Related]
4. [Comorbidity, anemia and response to erythropoiesis stimulating agents in chronic hemodialysis].
Anaya S; Rivera F; Sánchez de la Nieta MD; Carreño A; Vozmediano C; Alcaide MP; Arambarri M; Nieto J; Caparrós G; Ferreras I
Nefrologia; 2008; 28(2):186-92. PubMed ID: 18454709
[TBL] [Abstract][Full Text] [Related]
5. Erythropoiesis stimulating agents, thrombosis and cancer.
Barbera L; Thomas G
Radiother Oncol; 2010 Jun; 95(3):269-76. PubMed ID: 20219259
[TBL] [Abstract][Full Text] [Related]
6. Erythropoietin in cancer-related anemia.
Fenner MH; Ganser A
Curr Opin Oncol; 2008 Nov; 20(6):685-9. PubMed ID: 18841051
[TBL] [Abstract][Full Text] [Related]
7. Venous thromboembolic events and erythropoiesis-stimulating agents: an update.
Dicato M
Oncologist; 2008; 13 Suppl 3():11-5. PubMed ID: 18458119
[TBL] [Abstract][Full Text] [Related]
8. Erythropoietin in cancer patients: pros and cons.
Dicato M; Plawny L
Curr Opin Oncol; 2010 Jul; 22(4):307-11. PubMed ID: 20498598
[TBL] [Abstract][Full Text] [Related]
9. Thromboembolism in hospitalized neutropenic cancer patients.
Khorana AA; Francis CW; Culakova E; Fisher RI; Kuderer NM; Lyman GH
J Clin Oncol; 2006 Jan; 24(3):484-90. PubMed ID: 16421425
[TBL] [Abstract][Full Text] [Related]
10. Thrombosis as a harbinger of cancer.
Prandoni P; Piccioli A
Curr Opin Hematol; 2006 Sep; 13(5):362-5. PubMed ID: 16888442
[TBL] [Abstract][Full Text] [Related]
11. Cancer and venous thromboembolism: an overview.
Prandoni P; Piccioli A; Girolami A
Haematologica; 1999 May; 84(5):437-45. PubMed ID: 10329923
[TBL] [Abstract][Full Text] [Related]
12. [Cancer and venous thromboembolism].
Meyer G; Belmont L
Rev Mal Respir; 2011 Apr; 28(4):443-52. PubMed ID: 21549900
[TBL] [Abstract][Full Text] [Related]
13. Review: erythropoiesis-stimulating agents increase mortality in patients with cancer.
Matulonis U
Evid Based Med; 2009 Dec; 14(6):182. PubMed ID: 19949184
[No Abstract] [Full Text] [Related]
14. Venous thromboembolism and cancer: a two-way clinical association.
Agnelli G
Thromb Haemost; 1997 Jul; 78(1):117-20. PubMed ID: 9198139
[TBL] [Abstract][Full Text] [Related]
15. Erythropoiesis-stimulating agents for anemic patients with cancer.
Sheikh S; Littlewood TJ
Expert Rev Hematol; 2010 Dec; 3(6):697-704. PubMed ID: 21091146
[TBL] [Abstract][Full Text] [Related]
16. Management of anaemia in prostate cancer.
Colloca G; Venturino A; Vitucci P; Gianni W
Cancer Invest; 2010 Mar; 28(3):280-8. PubMed ID: 19863346
[TBL] [Abstract][Full Text] [Related]
17. Risk factors for venous thromboembolism in children.
Gerotziafas GT
Int Angiol; 2004 Sep; 23(3):195-205. PubMed ID: 15765033
[TBL] [Abstract][Full Text] [Related]
18. Prognosis of cancers associated with venous thromboembolism.
Sørensen HT; Mellemkjaer L; Olsen JH; Baron JA
N Engl J Med; 2000 Dec; 343(25):1846-50. PubMed ID: 11117976
[TBL] [Abstract][Full Text] [Related]
19. [Venous thromboembolism and neoplasms].
Alatri A; Carnovali M; Prandoni P
Ann Ital Med Int; 2000; 15(2):156-65. PubMed ID: 10920506
[TBL] [Abstract][Full Text] [Related]
20. Venous thromboembolism and cancer: prevention and therapy.
Lee AY
Vnitr Lek; 2006 Mar; 52 Suppl 1():127-8, 130-1. PubMed ID: 16637461
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
